The “Green Rush” of cannabis and hemp continues to increase because of the medicinal and health benefits of these two plants. The two major beneficial compound classes are the cannabinoids and terpenes.
The Hippocratic Oath charges medical doctors to uphold specific covenants throughout their career as physicians.
On October 5, 2019, CannaSafe released our initial findings into the sudden appearance of multiple e-cigarette, or vaping, product use associated lung injury (EVALI) (1) cases across the country.
With the rise of cannabis legalization across North America has come a rise in the prevalence of niche expertise in the cannabis sector.
On December 30, 2019, researchers from the Department of Life Sciences at the University of Modena and Reggio Emilia and the Institute of Nanotechnology of the National Council of Research (CNR NANOTEC) in Italy published an exciting manu
A long history of cannabis discoveries and research has put Israel at the forefront of medical cannabis developments, worldwide collaborations, and investor activity.
A review of the literature to examine the analgesic properties of cannabis.
The National Center for Complementary and Integrative Health (NCCIH), part of the NIH, announced funding for nine new research awards totaling $3 million to study the potential pain-relieving properties of cannabinoids and terpenes in cannabis.
The U.S. Drug Enforcement Administration (DEA) announced in a press release (1) that it is moving forward to facilitate and expand scientific and medical research for cannabis in the United States.
Lake Superior State University (LSSU) announced a strategic partnership with Agilent Technologies to facilitate education and research in cannabis chemistry and analysis through the LSSU Cannabis Center of Excellence (CoE).